FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022851015> ?p ?o ?g. }

• W2022851015 endingPage "194" @default.
• W2022851015 startingPage "194" @default.
• W2022851015 abstract "Background: In spite of being the preferred induction agent for LMA insertion, propofol has many undesirable side effects including dose-related cardiorespiratory depression and local pain at injection site. Ketofol as a novel induction agent has been introduced recently with comparable efficacy and improved hemodynamic control .Objective: To investigate ketofol as a suitable induction agent alternative to propofol for insertion of LMA in children considering insertion conditions, hemodynamic stability, local pain at injection site, and recovery. Materials and Methods: In this randomized, double-blind study, 100 children were randomly assigned into two groups of 50 patients each in which induction was performed with either propofol or ketofol. Providers were given one 20 ml syringe [represent either 2 mg/kg of propofol (P group) or 0.75 mg/kg of ketamine and 1.5 mg/kg of propofol (KP group)] and one 10 ml syringe for rescue if needed [represent 1 mg/kg of propofol (P group) or 0.25 mg/kg of ketamine and 0.5 mg/kg of propofol (KP group)]. After monitoring with bispectral index (BIS), general anesthesia was induced by infusion with a syringe perfuser at a constant rate of 250 ml/h with either of the two agents till the BIS values decreased to 40. Mean arterial pressure (MAP), heart rate (HR) were measured every 30 seconds up to 5 minutes after LMA placement. The time till BIS values decreased to 40 was measured. All children were evaluated for incidence of apnea, pain on injection, jaw relaxation, conditions for LMA insertion, and complications such as muscle rigidity, hallucinations, and excessive secretions. Results: Induction time (time to reach BIS of 40) was faster in the KP group (150 ΁ 23.5 seconds) than in the P group (205 ΁ 37.4 seconds). The incidence of injection pain was significantly lower in the KP group (10%) than in the P group (80%). Excellent jaw relaxation and full mouth opening were higher in the KP group [45 patients (90%)] than in the P group [38 patients (76%)]. Excellent LMA insertion conditions were observed in 45 patients (90%) in the KP group and 38 patients (76%) in the P group. The KP group showed preserved hemodynamic stability (mean blood pressure, heart rate) with less incidence and duration of apnea compared to the P group. Conclusion: ketofol is a safe and effective alternative induction agent for LMA insertion in children with rapid onset of action and lower incidence of injection pain. It provided better LMA insertion conditions, improved hemodynamic stability with less prolonged apnea when compared with propofol." @default.
• W2022851015 created "2016-06-24" @default.
• W2022851015 creator A5044492242 @default.
• W2022851015 creator A5068442157 @default.
• W2022851015 date "2013-01-01" @default.
• W2022851015 modified "2023-09-26" @default.
• W2022851015 title "A clinical comparison of ketofol (ketamine and propofol admixture) versus propofol as an induction agent on quality of laryngeal mask airway insertion and hemodynamic stability in children" @default.
• W2022851015 cites W116172742 @default.
• W2022851015 cites W1509154185 @default.
• W2022851015 cites W1512956826 @default.
• W2022851015 cites W1569696605 @default.
• W2022851015 cites W1963570017 @default.
• W2022851015 cites W1964086840 @default.
• W2022851015 cites W1967416443 @default.
• W2022851015 cites W1975927594 @default.
• W2022851015 cites W1986286802 @default.
• W2022851015 cites W1991695733 @default.
• W2022851015 cites W1994017467 @default.
• W2022851015 cites W2013976047 @default.
• W2022851015 cites W2015016817 @default.
• W2022851015 cites W2027540197 @default.
• W2022851015 cites W2032051250 @default.
• W2022851015 cites W2032065278 @default.
• W2022851015 cites W2035230043 @default.
• W2022851015 cites W2058123932 @default.
• W2022851015 cites W2062103966 @default.
• W2022851015 cites W2064194588 @default.
• W2022851015 cites W2067982711 @default.
• W2022851015 cites W2072712155 @default.
• W2022851015 cites W2073569131 @default.
• W2022851015 cites W2073749295 @default.
• W2022851015 cites W2079170612 @default.
• W2022851015 cites W2081800185 @default.
• W2022851015 cites W2107515212 @default.
• W2022851015 cites W2110104456 @default.
• W2022851015 cites W2114796727 @default.
• W2022851015 cites W2142054586 @default.
• W2022851015 cites W2147481630 @default.
• W2022851015 cites W2154357825 @default.
• W2022851015 cites W2154581149 @default.
• W2022851015 cites W2156769260 @default.
• W2022851015 cites W2398508198 @default.
• W2022851015 doi "https://doi.org/10.4103/0259-1162.118957" @default.
• W2022851015 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4173531" @default.
• W2022851015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25885832" @default.
• W2022851015 hasPublicationYear "2013" @default.
• W2022851015 type Work @default.
• W2022851015 sameAs 2022851015 @default.
• W2022851015 citedByCount "16" @default.
• W2022851015 countsByYear W20228510152016 @default.
• W2022851015 countsByYear W20228510152017 @default.
• W2022851015 countsByYear W20228510152018 @default.
• W2022851015 countsByYear W20228510152019 @default.
• W2022851015 countsByYear W20228510152020 @default.
• W2022851015 countsByYear W20228510152022 @default.
• W2022851015 countsByYear W20228510152023 @default.
• W2022851015 crossrefType "journal-article" @default.
• W2022851015 hasAuthorship W2022851015A5044492242 @default.
• W2022851015 hasAuthorship W2022851015A5068442157 @default.
• W2022851015 hasBestOaLocation W20228510152 @default.
• W2022851015 hasConcept C105922876 @default.
• W2022851015 hasConcept C126322002 @default.
• W2022851015 hasConcept C178853913 @default.
• W2022851015 hasConcept C2776277131 @default.
• W2022851015 hasConcept C2776452961 @default.
• W2022851015 hasConcept C2776814716 @default.
• W2022851015 hasConcept C2776900724 @default.
• W2022851015 hasConcept C2777953023 @default.
• W2022851015 hasConcept C2780795376 @default.
• W2022851015 hasConcept C2781097354 @default.
• W2022851015 hasConcept C2781326671 @default.
• W2022851015 hasConcept C42219234 @default.
• W2022851015 hasConcept C71924100 @default.
• W2022851015 hasConcept C84393581 @default.
• W2022851015 hasConceptScore W2022851015C105922876 @default.
• W2022851015 hasConceptScore W2022851015C126322002 @default.
• W2022851015 hasConceptScore W2022851015C178853913 @default.
• W2022851015 hasConceptScore W2022851015C2776277131 @default.
• W2022851015 hasConceptScore W2022851015C2776452961 @default.
• W2022851015 hasConceptScore W2022851015C2776814716 @default.
• W2022851015 hasConceptScore W2022851015C2776900724 @default.
• W2022851015 hasConceptScore W2022851015C2777953023 @default.
• W2022851015 hasConceptScore W2022851015C2780795376 @default.
• W2022851015 hasConceptScore W2022851015C2781097354 @default.
• W2022851015 hasConceptScore W2022851015C2781326671 @default.
• W2022851015 hasConceptScore W2022851015C42219234 @default.
• W2022851015 hasConceptScore W2022851015C71924100 @default.
• W2022851015 hasConceptScore W2022851015C84393581 @default.
• W2022851015 hasIssue "2" @default.
• W2022851015 hasLocation W20228510151 @default.
• W2022851015 hasLocation W20228510152 @default.
• W2022851015 hasLocation W20228510153 @default.
• W2022851015 hasLocation W20228510154 @default.
• W2022851015 hasOpenAccess W2022851015 @default.
• W2022851015 hasPrimaryLocation W20228510151 @default.
• W2022851015 hasRelatedWork W2022851015 @default.
• W2022851015 hasRelatedWork W2222045191 @default.
• W2022851015 hasRelatedWork W2328511641 @default.

• next